Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,920.50    -17.50 (-0.90%)
Bid:
1,920.50
Ask:
1,921.50
Spread: 1.00 (0.052%)
Market Cap: £77.02b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

FTSE 100 makes record close, GSK at 26-year high after earnings impress
4 Feb 2026

FTSE 100 makes record close, GSK at 26-year high after earnings impress

Feb 4 (Reuters) - The UK's ‍FTSE 100 closed at a record high on Wednesday, boosted by healthcare stocks led by drugmaker GSK ⁠after upbeat quarterly e...

LONDON MARKET CLOSE: FTSE 100 tops 10,400 as Beazley and Entain soar
4 Feb 2026

LONDON MARKET CLOSE: FTSE 100 tops 10,400 as Beazley and Entain soar

(Alliance News) - The FTSE 100 surged to a fresh high on Wednesday, spurred by strong trading updates and as insurer Beazley said it has accepted a po...

LONDON MARKET MIDDAY: FTSE 100 strengthens as Beazley and GSK rise
4 Feb 2026

LONDON MARKET MIDDAY: FTSE 100 strengthens as Beazley and GSK rise

(Alliance News) - Stock prices in London were higher at midday on Wednesday, despite ongoing jitters over the impact of the latest artificial intellig...

Global software stocks hit by Anthropic wake-up call on AI disruption
4 Feb 2026

Global software stocks hit by Anthropic wake-up call on AI disruption

MILAN, Feb 4 (Reuters) - European and U.S. software stocks struggled to find support on Wednesday as a sector-wide selloff spread ‍to Asia, fuelled by...

Global software stocks hit by Anthropic wake-up call on AI disruption
4 Feb 2026

Global software stocks hit by Anthropic wake-up call on AI disruption

MILAN, Feb 4 (Reuters) - A deep selloff in global software stocks entered a second day on Wednesday, reflecting growing concerns ‍about how advances i...

GSK optimistic for 2026 after fourth-quarter results beat forecast
4 Feb 2026

GSK optimistic for 2026 after fourth-quarter results beat forecast

(Alliance News) - GSK PLC on Wednesday backed guidance after fourth-quarter results beat expectations, driven by growth in its Specialty Medicines an...

LONDON BRIEFING: Zurich agrees terms for GBP8.0 billion Beazley offer
4 Feb 2026

LONDON BRIEFING: Zurich agrees terms for GBP8.0 billion Beazley offer

(Alliance News) - Beazley agrees to takeover terms for a GBP8.0 billion takeover by Zurich Insurance, while GSK reports "another strong performance" h...

GSK sees slower sales growth in 2026 as patent loss looms
4 Feb 2026

GSK sees slower sales growth in 2026 as patent loss looms

(Sharecast News) - UK pharma giant GSK said turnover growth would slow this financial year as it looked to counter the expiry of an HIV drug patent an...